Sarah K. Dutcher, PhD, MS

Lead Epidemiologist
Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration

Poster(s):

• (097) COVID-19 Related Changes in Healthcare Utilization Among Insured Persons in the US and its Impact on Pharmacoepidemiologic Research
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (231) Characterizing inpatient electronic health records (EHR) from a large hospital network for use in neonatal pharmacoepidemiology studies in the United States
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST

• (302) Prenatal syphilis in the US: characterizing screening and treatment during pregnancy in publicly and commercially insured individuals
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST

• (ASPOT05) Untangling National Medicaid Data: 30 Data Quality Metrics to Support Maternal Health Studies in Two Common Data Models
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST